10/9/2012 8:02:18 AM
Dr. Reddy's Laboratories' Custom Pharmaceutical Services (CPS) business has expanded its manufacturing operations in Mirfield, UK. With the commercial development at its facility in Mirfield, CPS expands in the areas of activated mPEG manufacturing and in the development and manufacture of New Chemical Entities (NCE) APIs for use in pre-clinical research. Dr. Reddy's Pharmaceutical Services and Active Ingredients business president Dr. Ananthanarayanan said the expansion will enable the company to provide a finer network of cGMP manufacturing to support its global customer base. "PEGylation is one area where we felt the need for expanding our capabilities. We have invested in multiple technology areas and the expansion will add significant value in the areas of mPEGs and cGMP API manufacturing," Dr. Ananthanarayanan added.
comments powered by